Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer – Ovarian Cancer News Today
Ovarian Cancer News Today |
Celyad's CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer
Ovarian Cancer News Today Celyad's NKR-2 CAR T-cell therapy is a personalized therapy that isolates a patient's own T-cells, a type of white blood cell, and adds a protein called NKG2D to the cells. NKG2D helps T-cells recognize and kill tumor cells. Once they are “armed” with … |
